Corroborating findings were reported in a previous research that c-MYC was upregulated in CD133 colon cancer stem cells, and that upregulated c-MYC caused cell proliferation and chemoresistance of colon cancer [39]. This evidence concerns the gene MYC and malignant colon neoplasm.